Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Fulgent Genetics Q2 Adj. EPS $0.07 Beats $(0.18) Estimate, Sales $81.803M Beat $76.205M Estimate

Author: Benzinga Newsdesk | August 01, 2025 06:01am
Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(0.18) by 138.25 percent. This is a 53.33 percent decrease over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $81.803 million which beat the analyst consensus estimate of $76.205 million by 7.35 percent. This is a 15.17 percent increase over sales of $71.028 million the same period last year.

Posted In: FLGT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist